IQ Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Neurovalens develops medical devices using neuromodulation technology to address health conditions including obesity and anxiety disorders.
BiotechDeep TechHealthtechMedical DevicesMental HealthNorthern Ireland, GB
Dr. Jason McKeown(MD PhD, Founder)
Co-investorsACF InvestorsClarendon Fund Managers Ltd.StartXBeltrae PartnersBritish Business BankInnovation Ulster+2 more
Tagomics develops multimodal technologies for precision medicine and next-generation diagnostics.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, GB
Dr Jack Kennefick(Co-founder, Director & Chief Executive Officer)Dr Robert Neely(Co-founder, Director & Chief Scientific Officer)
Co-investorsCalculus Capital Ltd.Illumina VenturesStart CodonCalculusIllumina InnovationInnovate UK+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.









